Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

376 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinical outcome of patients who reduced sunitinib or pazopanib during first-line treatment for advanced kidney cancer.
Iacovelli R, Cossu Rocca M, Galli L, De Giorgi U, Sabbatini R, Santoni M, Mosca A, Fornarini G, Massari F, Masini C, Bersanelli M, Biasco E, Lolli C, Guida A, Berardi R, Terrone C, Pastorino A, Ardizzoni A, Pinto C, Buti S, Nolè F, Tortora G. Iacovelli R, et al. Among authors: terrone c. Urol Oncol. 2017 Sep;35(9):541.e7-541.e13. doi: 10.1016/j.urolonc.2017.05.007. Epub 2017 May 29. Urol Oncol. 2017. PMID: 28572027
Oral estramustine plus oral etoposide in the treatment of hormone refractory prostate cancer patients: a phase II study with a 5-year follow-up.
Berruti A, Fara E, Tucci M, Tarabuzzi R, Mosca A, Terrone C, Gorzegno G, Fasolis G, Tampellini M, Porpiglia F, De Stefanis M, Fontana D, Bertetto O, Dogliotti L; Gruppo Onco-Urologico Piemontese, Rete Oncologica Piemontese. Berruti A, et al. Among authors: terrone c. Urol Oncol. 2005 Jan-Feb;23(1):1-7. doi: 10.1016/j.urolonc.2004.06.003. Urol Oncol. 2005. PMID: 15885575 Clinical Trial.
Docetaxel plus androgen deprivation withdrawal may restore sensitivity to luteinizing hormone-releasing hormone analog therapy in castration-resistant prostate cancer patients.
Bedussi F, Valcamonico F, Mosca A, Sigala S, Ferrari L, Terrone C, Volta AD, Marchioro G, Ferrari V, Alabiso O, Memo M, Berruti A. Bedussi F, et al. Among authors: terrone c. Endocrine. 2016 Dec;54(3):830-833. doi: 10.1007/s12020-015-0827-z. Epub 2015 Dec 21. Endocrine. 2016. PMID: 26690656 No abstract available.
The outcome to axitinib or everolimus after sunitinib in metastatic renal cell carcinoma.
Iacovelli R, Cossu Rocca M, Galli L, Sabbatini R, De Giorgi U, Santini D, Facchini G, Mosca A, Atzori F, Zucali P, Fornarini G, Massari F, Buti S, Ricotta R, Masini C, Toscani I, Biasco E, Guida A, Lolli C, De Lisi D, Rossetti S, Terrone C, Scartozzi M, Miggiano C, Pastorino A, Bersanelli M, Carlo-Stella G, Pinto C, Nobili E, Nolè F, Tortora G, Porta C. Iacovelli R, et al. Among authors: terrone c. Anticancer Drugs. 2018 Aug;29(7):705-709. doi: 10.1097/CAD.0000000000000632. Anticancer Drugs. 2018. PMID: 29846246
Autophagic Gene Polymorphisms in Liquid Biopsies and Outcome of Patients with Metastatic Clear Cell Renal Cell Carcinoma.
Santoni M, Piva F, De Giorgi U, Mosca A, Basso U, Santini D, Buti S, Lolli C, Terrone C, Maruzzo M, Iuliani M, Bersanelli M, Conti A, Mazzucchelli R, Montironi R, Burattini L, Berardi R. Santoni M, et al. Among authors: terrone c. Anticancer Res. 2018 Oct;38(10):5773-5782. doi: 10.21873/anticanres.12916. Anticancer Res. 2018. PMID: 30275199
Curative Lung Metastasectomy Without Concomitant Androgen Deprivation Therapy in Oligometastatic Castration-resistant Prostate Cancer: A Case Report and Review of the Literature.
Mosca A, Mantica G, Giavarra M, Perrone V, De Marchi L, Gennari A, Toncini C, Terrone C. Mosca A, et al. Among authors: terrone c. Clin Genitourin Cancer. 2020 Jun;18(3):e295-e299. doi: 10.1016/j.clgc.2019.11.018. Epub 2019 Dec 4. Clin Genitourin Cancer. 2020. PMID: 31917170 Review. No abstract available.
IO-IO vs IO-TKI efficacy in metastatic kidney cancer patients: A structured systematic review over time.
Hoeh B, Flammia RS, Hohenhorst L, Sorce G, Panunzio A, Tappero S, Tian Z, Saad F, Gallucci M, Briganti A, Terrone C, Shariat SF, Graefen M, Tilki D, Antonelli A, Kosiba M, Kluth LA, Becker A, Chun FKH, Karakiewicz PI. Hoeh B, et al. Among authors: terrone c. Semin Oncol. 2022 Oct;49(5):394-399. doi: 10.1053/j.seminoncol.2022.10.001. Epub 2022 Oct 23. Semin Oncol. 2022. PMID: 36333148 Review.
Collecting duct carcinoma: Epidemiology, clinical characteristics and survival.
Panunzio A, Tappero S, Hohenhorst L, Cano Garcia C, Piccinelli M, Barletta F, Tian Z, Tafuri A, Briganti A, De Cobelli O, Chun FKH, Tilki D, Terrone C, Kapoor A, Saad F, Shariat SF, Cerruto MA, Antonelli A, Karakiewicz PI. Panunzio A, et al. Among authors: terrone c. Urol Oncol. 2023 Feb;41(2):110.e7-110.e14. doi: 10.1016/j.urolonc.2022.11.009. Epub 2022 Nov 28. Urol Oncol. 2023. PMID: 36456452
Impact of smoking exposure on disease progression in high risk and very high-risk nonmuscle invasive bladder cancer patients undergoing BCG therapy.
Contieri R, Claps F, Hurle R, Buffi NM, Lughezzani G, Lazzeri M, Aveta A, Pandolfo S, Porpiglia F, Fiori C, Barone B, Crocetto F, Ditonno P, Lucarelli G, Lasorsa F, Busetto GM, Falagario U, Giudice FD, Maggi M, Cantiello F, Borghesi M, Terrone C, Bove P, Antonelli A, Veccia A, Mari A, Luzzago S, Todea-Moga C, Minervini A, Musi G, Fallara G, Mistretta FA, Bianchi R, Tozzi M, Soria F, Gontero P, Marchioni M, Janello LMI, Terracciano D, Russo GI, Schips L, Perdonà S, Tataru OS, Vartolomei MD, Autorino R, Catellani M, Sighinolfi C, Montanari E, Stasi SMD, Rocco B, de Cobelli O, Ferro M. Contieri R, et al. Among authors: terrone c. Urol Oncol. 2024 Dec 12:S1078-1439(24)00748-8. doi: 10.1016/j.urolonc.2024.11.015. Online ahead of print. Urol Oncol. 2024. PMID: 39672689
376 results